American Healthcare REIT (AHR) Stock: Buy, Sell, or Hold?
AHR - American Healthcare REIT, Inc.
$53.40
0.54 (1.02%)
▲
5d:
+0.74%
30d:
+3.29%
90d:
-7.03%
WAIT
LOW Confidence
Analysis Updated: Oct 22, 2026 12:00 AM ET
Earnings: Nov 05, 2026
12d
Get Alerted When AHR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: AHR shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: AHR shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$48.20
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$29.93
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: AHR is currently trading at $53.40, which is considered extended relative to its 30-day fair value range of $50.94 to $53.20. The stock's valuation (Forward PE: 53.9) is in line with its historical norms (59.4). Remarkably, the market is currently pricing in an annual earnings decline of 3.1% over the next few years. This pessimistic expectation contrasts with the company's recent 157.5% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, AHR is in a strong uptrend. The price is approaching resistance at $54.76. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: AHR scores 23/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $63.69 (+19.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, AHR is in a strong uptrend. The price is approaching resistance at $54.76. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: AHR scores 23/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $63.69 (+19.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$50.94 -
$53.20
Company Quality Score
41/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
26.2%
All Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (23/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($63.69)
- WARNING: Composite score 41/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$50.94 -
$53.20
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$50.26
Resistance Level
$54.76
Current Trend
Strong Uptrend
Technical data as of
Oct 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
53.94
Wall Street Target
$63.69
(+19.3%)
Revenue Growth (YoY)
24.7%
Earnings Growth (YoY)
157.5%
Profit Margin
4.8%
Valuation Discount vs History
-3.1% cheaper
PE vs Historical
53.9 vs 59.4
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-3.1%
(market-implied from PE analysis)
1-Year Target
$51.74
(-3%)
2-Year Target
$50.14
(-6%)
3-Year Target
$48.59
(-9%)
3-Yr Target (if PE normalizes)
(PE: 54→59)
$53.50
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 53.9, Growth: 60.0%)
$180.22
(+238%)
Base:
(SPY PE: 19.9, Growth: 60.0%)
$66.36
(+24%)
Bear:
(PE: 16.9, Growth: 60.0%)
$56.40
(+6%)
📈
Valuation based on Current Earnings
Forward PE: 48.08 | Forward EPS (Implied): $1.11
Bull Case
$64.48
(+21%)
Analyst growth 15.0%, PE expands to 50.5
Base Case
$53.40
(0%)
Market implied 0.0%, PE stable at 48.1
Bear Case
$40.85
(-24%)
Severe decline -15.0%, PE contracts to 43.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 53.9 to 59.4
Stabilization Target:
$58.81
(+10.1%)
PE Expansion Potential:
+10.1%
Share & Embed Analysis
Last updated: October 22, 2026 7:28 PM ET
Data refreshes hourly during market hours. Next update: 8:28 PM
Data refreshes hourly during market hours. Next update: 8:28 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AHR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated REIT - Healthcare Facilities Stocks
Top-rated stocks in REIT - Healthcare Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VTR
Ventas Inc |
STRONG BUY
23 analysts |
$101 | 55 HOLD |
|
WELL
Welltower Inc |
STRONG BUY
22 analysts |
$261 | 53 HOLD |
|
CTRE
CareTrust REIT Inc. |
STRONG BUY
13 analysts |
$44 | 66 BUY |
|
DOC
Healthpeak Properties Inc |
HOLD
22 analysts |
$23 | 61 BUY |
|
OHI
Omega Healthcare Investo… |
HOLD
20 analysts |
$51 | 65 BUY |
